Infection and Response - Worksheets, Questions and Revision
41 original exam-style questions - 17 pages of questions with a full mark scheme - free printable PDF.
Infection and Response revision guideMore GCSE Science practiceMock exams
This topic is chapter 2 of GCSE Biology Topic Workbook 2 and chapter 9 of GCSE Biology 10-Minute Tests.
1.3 Infection and Response
- A) Virus
- B) Bacterium
- C) Fungus
- D) Protist
- A) Virus
- B) Bacterium
- C) Fungus
- D) Protist
- A) Virus
- B) Bacterium
- C) Fungus
- D) Protist
- A) Virus
- B) Bacterium
- C) Fungus
- D) Protist
Week 1: 6.0
Week 5: 1.5
Between week 1 and week 5 a vaccination campaign reached 60% of the population. Calculate the percentage decrease in incidence per 1000 people from week 1 to week 5 and discuss one reason why the decrease might not be entirely due to vaccination.
Question 1
- (a) correct example e.g. malaria spread by mosquitoesB1
- (a) Answer: Malaria spread by mosquitoes.
- (b) correct method such as using insect nets, removing standing water, using insect repellent, or spraying insects, oeB1
- (b) Answer: Use insect nets or remove standing water where mosquitoes breed.
Question 2
- (a) removes microbes and dirt from skin so fewer pathogens transferred to others or to mouth/food, oeB1
- (a) Answer: Washing hands removes microbes and dirt, so fewer pathogens are transferred to others or to food.
- (b) stops droplets containing pathogens spreading into the air and onto surfaces, so fewer people inhale or touch them, oeB1
- (b) Answer: It stops droplets with pathogens spreading into the air and onto surfaces, reducing transmission.
- (c) a dressing covers the wound so pathogens cannot enter or leave easily, reducing contamination and spread, oeB1
- (c) Answer: A dressing covers the wound so pathogens cannot easily enter or leave, reducing contamination.
Question 3
- (a) a single bacterial cell divides into two identical daughter cells, oeB1
- (a) Answer: A single bacterial cell divides to form two identical daughter cells.
- (b) a correct condition, e.g. warm temperature, plenty of nutrients, or moist environment, oeB1
- (b) Answer: Warm temperature (or plenty of nutrients or moist conditions).
Question 4
- (a) ingest and destroy pathogens (phagocytosis) or produce antibodies to target pathogens, oeB1
- (a) Answer: They ingest and destroy pathogens (phagocytosis) or produce antibodies to target pathogens.
- (b) antibodies caoB1
- (b) Answer: Antibodies.
Question 5
- (a) Class BB1
- (a) Answer: Class B.
- (b) total = 4 + 1 + 5 = 10B1
- (b) Answer: 10 cases
Question 6
- (a) B (bacterium)B1
- (a) Answer: B
- (b) A (virus)B1
- (b) Answer: A
- (c) D (protist)B1
- (c) Answer: D
- (d) C (fungus)B1
- (d) Answer: C
Question 7
- (a) 10 - 6 = 4 days decreaseB1
- (a) Answer: 4 days
- (b) yes, the drug reduces recovery time, suggesting it is effective, oeB1
- (b) Answer: Yes. Recovery time is reduced from 10 to 6 days, suggesting the drug is effective.
Question 8
- (a) states that antibiotics target structures or processes specific to bacterial cells (cell wall, bacterial enzymes) not present in virusesM1
- (a) antibiotics therefore do not affect viruses which replicate inside host cells and lack those bacterial targets, oeA1
- (a) Answer: Antibiotics target features of bacterial cells such as cell walls or enzymes that viruses do not have; viruses replicate inside host cells and lack those targets, so antibiotics do not work on them.
- (b) to reduce the risk of antibiotic resistance developing or to avoid unnecessary side effects, oeB1
- (b) Answer: To reduce the risk of bacteria developing antibiotic resistance.
Question 9
- (a) substitutes and calculates ratio: 400 / 100 = 4M1
- (a) population became 4 times larger caoA1
- (a) Answer: 4 times larger
- (b) correct reason: warm temperature, plenty of nutrients, or moist conditions that favour faster reproduction, oeB1
- (b) Answer: Because the conditions were ideal, for example the warm temperature allowed faster reproduction.
Question 10
- (a) antiseptics are applied to surfaces or skin to kill or reduce microbes externally; antibiotics are taken into the body to kill or inhibit bacteria internally, oeB1
- (a) Answer: Antiseptics are used on surfaces or skin to kill or reduce microbes externally, while antibiotics are taken to treat bacterial infections inside the body.
- (b) example such as cleaning a wound, disinfecting a table or surgical instrument, oeB1
- (b) Answer: Cleaning a wound or disinfecting a surface.
- (c) no, antibiotics are not effective against viruses caoB1
- (c) Answer: No, antibiotics are not effective against viruses.
Question 11
- (a) a disease that can be spread from one organism/person to another (oe)B1
- (a) Answer: A disease caused by a pathogen that can be passed from one organism to another.
- (b) any one correct method of transmission, e.g. direct contactB1
- (b) any second correct method of transmission, e.g. water, air/droplets, contaminated food, animal vectors, bodily fluids/sexual contactB1
- (b) Answer: Any two of: direct contact; contaminated water; air/droplet infection; contaminated food; animal vectors; bodily fluids.
Question 12
- (a) virusB1
- (a) Answer: Virus
- (b) feverB1
- (b) red skin rash (allow cough, red eyes)B1
- (b) Answer: Fever and a red skin rash (any two accepted symptoms).
- (c) measles can be fatal or cause serious complications, e.g. encephalitis (swelling of the brain) (oe)B1
- (c) vaccination protects the individual and contributes to herd immunity, reducing spread to vulnerable people who cannot be vaccinatedB1
- (c) Answer: Although most children recover, measles can occasionally be fatal or cause serious complications; vaccination also reduces spread to those who cannot be vaccinated (herd immunity).
Question 13
- (a) acts as a physical barrier to pathogensB1
- (a) produces sebum, an oily antimicrobial secretion, which inhibits the growth of pathogens on the skin's surfaceB1
- (a) Answer: It is a physical barrier and secretes antimicrobial sebum that inhibits pathogen growth.
- (b) hairs trap large particles/pathogensB1
- (b) mucus traps pathogens/particlesB1
- (b) Answer: Hairs and mucus in the nose trap pathogens and dust particles.
- (c) lined with mucus, which traps pathogensB1
- (c) lined with cilia, which waft/sweep the mucus (and trapped pathogens) up to the throat to be swallowedB1
- (c) Answer: Mucus traps pathogens and cilia sweep the mucus up to the throat to be swallowed.
Question 14
- (a) trials are usually controlled and can reduce bias by using control groups or randomisation, oeB1
- (a) large trials have more participants so results are more reliable and less likely due to chance, oeB1
- (a) observational studies can have confounding variables that are not controlled so cause and effect is less certain, oeB1
- (a) Answer: Controlled trials reduce bias (e.g. randomisation or control groups), large trials are more reliable with less chance variation, and observational studies may have confounding variables so cause and effect is less certain.
Question 15
- (a) one correct type of pathogen with a matching disease, e.g. bacterium - tuberculosis; virus - influenza; fungus - athlete foot; protozoan - malaria, oeB1
- (a) Answer: Any one correct pair, for example: bacterium - tuberculosis.
- (b) a second correct type and matching disease different from part a, oeB1
- (b) Answer: Any different correct pair, for example: virus - influenza.
Question 16
- (a) normal bacteria occupy niches and resources so reduce space and nutrients for pathogensM1
- (a) some produce harmful substances or change pH to inhibit pathogen growth, oeA1
- (a) Answer: Normal skin bacteria occupy space and resources preventing pathogen colonisation, and some release substances or alter pH that inhibit pathogen growth.
Question 17
- (a) one correct barrier with brief explanation, e.g. skin - acts as a continuous physical barrier stopping pathogens enteringB1
- (a) Answer: Skin acts as a continuous physical barrier that prevents pathogens entering the body.
- (b) one other correct barrier with brief explanation, e.g. mucus and cilia in the trachea trap and move microbes out of the airwaysB1
- (b) Answer: Mucus and cilia in the airways trap and move microbes out of the respiratory system.
Question 18
- (a) 90 new cases (50 x 1.8 = 90) caoB1
- (a) Answer: 90
Question 19
- (a) decrease = 8400 - 1260 = 7140M1
- (a) (7140 / 8400) x 100M1
- (a) 85% caoA1
- (a) Answer: 85% decrease
- (b) e.g. improved sanitation/hygiene, improved treatment or isolation of infected individuals, public health campaigns raising awarenessB1
- (b) Answer: For example, improved sanitation/hygiene or better isolation/treatment of infected individuals.
Question 20
- (a) eating food contaminated with the bacteria (oe)B1
- (a) Answer: By eating food contaminated with Salmonella bacteria.
- (b) feverB1
- (b) abdominal cramps / vomiting / diarrhoea (any one)B1
- (b) Answer: Any two of: fever; stomach cramps; vomiting; diarrhoea.
- (c) vaccination reduces the number of poultry/eggs infected with (or carrying) the bacteriaB1
- (c) this reduces the chance of the bacteria being passed on to humans through contaminated poultry meat or eggsB1
- (c) Answer: Fewer poultry carry the bacteria, so fewer contaminated eggs/meat reach humans, reducing human infection rates.
- (d) using a barrier method of contraception, e.g. a condomB1
- (d) treating both/all sexual partners with an appropriate antibioticB1
- (d) Answer: Using barrier contraception (e.g. condoms) and ensuring all sexual partners are treated with an effective antibiotic.
Question 21
- (a) stunted growth (allow reduced yield)B1
- (a) Answer: Stunted growth of the plant.
- (b) the mosaic pattern reduces the area of leaf that is green/contains chlorophyllB1
- (b) this reduces the rate of photosynthesis, so less glucose is available for growth, resulting in smaller plants/less fruitB1
- (b) Answer: Damaged, discoloured leaf tissue photosynthesises less, so less glucose is made for growth, reducing plant size and fruit yield.
- (c) use a testing kit containing monoclonal antibodies that bind specifically to TMV antigens/proteins (oe)B1
- (c) or take a sample and compare the symptoms/pathogen with a reference database or send to a laboratory for analysisB1
- (c) Answer: Use a monoclonal-antibody-based detection kit specific to TMV, or compare symptoms/sample against a reference database in a laboratory.
Question 22
- (a) a white blood cell (phagocyte) engulfs the pathogenB1
- (a) the pathogen is then digested/destroyed by the phagocyteB1
- (a) Answer: A phagocyte engulfs the pathogen and digests/destroys it.
- (b) lymphocytes produce antibodies that are specific/complementary to antigens on the surface of the pathogenB1
- (b) antibodies bind to the antigens, leading to destruction of the pathogen or clumping so it can be more easily engulfed by phagocytesB1
- (b) Answer: Lymphocytes make antibodies specific to the pathogen's antigens; the antibodies bind and help destroy or clump the pathogen.
- (c) lymphocytes produce antitoxinsB1
- (c) antitoxins neutralise the toxins produced by the bacteriaB1
- (c) Answer: Lymphocytes produce antitoxins, which neutralise the bacterial toxins.
Question 23
- Level 3 Detailed explanation. The answer links how vaccination stimulates an immune response producing memory cells and antibodies, how this provides faster protection on exposure reducing infection or severity, and explains herd immunity where high vaccination levels reduce overall pathogen transmission protecting unvaccinated or vulnerable people; includes clear causal links and an example or consequence.5-6
- Level 2 Some explanation. The answer states that vaccination stimulates immunity and reduces transmission in the population but the link between individual immunity and herd protection may be incomplete or only one example given.3-4
- Level 1 Simple statements. The answer mentions vaccination helps people not get sick or that it reduces spread, with little or no explanation of how or no mention of population-level effects.1-2
- Indicative content:
- Vaccination introduces antigens so the immune system produces antibodies and memory cells without causing full disease.
- Memory cells allow a faster, stronger immune response when the real pathogen is encountered, often preventing infection or reducing severity.
- Fewer infected individuals mean the pathogen has fewer hosts to infect, so transmission in the community falls.
- High vaccination coverage leads to herd immunity, protecting those who cannot be vaccinated (very young, immunocompromised).
- An example: if most people are vaccinated against measles, outbreaks are small and vulnerable people are less likely to be exposed.
Question 24
- (a) correct method: concentration = 8.00 / 4 / 5 or 8.00 x (1/4) x (1/5)M1
- (b) 0.400 mg L-1 caoA1
- (b) Answer: 0.400 mg L-1
Question 25
- (a) phagocyte engulfs bacteria by phagocytosis or surrounds and digests bacteria, oeM1
- (a) Answer: Phagocytes engulf and digest invading bacteria by phagocytosis.
- (b) lymphocytes (B cells) recognise antigens and produce specific antibodies against the pathogen, oeM1
- (b) Answer: Lymphocytes recognise antigens and B cells produce specific antibodies to target the bacteria.
- (c) combined idea: phagocytes remove many pathogens and lymphocyte antibodies neutralise and mark pathogens for destruction, and memory cells are produced giving long term immunity, oeM1
- (c) Answer: Phagocytes remove pathogens and lymphocyte-produced antibodies neutralise and mark pathogens for destruction; memory cells remain to give future immunity.
Question 26
- (a) antibiotics target bacterial structures or processes (cell wall synthesis, protein synthesis) not present in virusesM1
- (a) viruses replicate inside host cells using host machinery so antibiotics are ineffective caoA1
- (a) Answer: Antibiotics target bacterial structures or processes not present in viruses, and viruses replicate inside host cells using host machinery so antibiotics are ineffective.
Question 27
- (a) substitutes: N = 2.00 x 103 x 2180/30 or N = 2.00 x 103 x 26M1
- (b) 1.28 x 105 bacteria caoA1
- (b) Answer: 1.28 x 105 bacteria
Question 28
- (a) antibodies bind to specific antigens, neutralise pathogens or mark them for destruction by other immune cells, oeB1
- (a) Answer: Antibodies bind specific antigens to neutralise pathogens or mark them for destruction.
- (b) memory cells remain after first exposure and allow a faster, larger immune response on re-exposure to the same pathogen, oeB1
- (b) Answer: Memory cells remain and cause a faster, larger immune response on re-exposure to the same pathogen.
- (c) combined explanation: memory cells trigger rapid production of specific antibodies on re-exposure, preventing disease development, oeM1
- (c) Answer: Memory cells trigger rapid production of specific antibodies on re-exposure, preventing disease development.
Question 29
- mutations occur naturally/randomly in bacterial DNAB1
- some mutations may result in bacteria being resistant to an antibioticB1
- when the antibiotic is used, non-resistant bacteria are killed, but resistant bacteria survive (selection pressure)B1
- surviving resistant bacteria reproduce, passing on the resistance allele/gene to their offspringB1
- over many generations, the proportion of resistant bacteria in the population increases (natural selection); overuse or incomplete courses of antibiotics increase the rate at which this happensB1
- Answer: Indicative content - award any 5 of the marking points listed, max 5 marks.
Question 30
- (a) tested in the laboratory on human cells and tissues, then on live animals (preclinical testing)B1
- (a) this tests for toxicity and finds a suitable dosage before human trialsB1
- (a) this protects human volunteers from unnecessary harm before any human testing takes placeB1
- (a) Answer: Drugs are first tested on cells/tissues and live animals (preclinical testing) to check for toxicity and find a safe dose, protecting future human volunteers.
- (b) to test for/check for any side effects or toxicity in humansB1
- (b) a low dose and small number of people minimises the risk/harm to volunteers if there is an unexpected adverse reactionB1
- (b) Answer: A low dose in few healthy volunteers checks for side effects/toxicity while minimising risk if there is an unexpected reaction.
- (c) double-blind trialB1
- (c) Answer: A double-blind trial.
- (d) the placebo allows a comparison to be made, so any improvement caused by the drug itself can be identified, rather than the placebo effectB1
- (d) the double-blind design prevents bias from patients' or doctors' expectations affecting the results or how they are interpretedB1
- (d) Answer: The placebo lets researchers separate real drug effects from the placebo effect; being double-blind stops patient or doctor expectations biasing the results.
Question 31
- (a) e.g. a waxy cuticle on the leaf surface, or a cellulose cell wallB1
- (a) acts as a barrier that prevents pathogens from entering the plant tissueB1
- (a) Answer: The waxy cuticle (or cellulose cell wall) acts as a physical barrier preventing pathogen entry.
- (b) e.g. production of antibacterial chemicals or poisonsB1
- (b) these kill pathogens directly or deter herbivores/insects from feeding on the plantB1
- (b) Answer: Plants produce antibacterial chemicals or poisons that kill pathogens or deter herbivores from feeding.
- (c) e.g. thorns, hairs, leaves that droop or curl when touched, or mimicryB1
- (c) these deter animals/insects from eating or landing on/laying eggs on the plantB1
- (c) Answer: Thorns or hairs deter animals from eating the plant; drooping/curling leaves deter feeding insects.
Question 32
- Level 1 Simple statements are made about vaccination or about herd immunity, with little detail and little or no linkage between ideas.1-2
- Level 2 The process of vaccination in the body is described, with some description of herd immunity. Some logical linkage between points is shown.3-4
- Level 3 A detailed, coherent explanation links the body's response to vaccination with herd immunity in the population, showing a clear chain of reasoning throughout.5-6
- Indicative content:
- Vaccination involves injecting a small/dead/inactive quantity of the pathogen (or its antigens)
- This stimulates white blood cells (lymphocytes) to produce antibodies specific to the antigens
- Memory lymphocytes remain in the blood after vaccination
- If the person is later exposed to the live pathogen, memory cells enable rapid production of antibodies (secondary response)
- The pathogen is destroyed before the person becomes ill, so they do not develop symptoms and cannot pass the disease on
- If a large enough proportion of the population is vaccinated, the pathogen cannot spread easily because there are fewer people it can infect
- This reduces the overall spread of the disease, protecting unvaccinated individuals (e.g. babies, those who cannot be vaccinated) - herd immunity
Question 33
- (a) shows correct method: percentage decrease = (6.0 - 1.5)/6.0 x 100 or equivalentM1
- (a) 75% decrease caoA1
- (a) Answer: 75% decrease
- (b) one plausible alternative with brief explanation, e.g. seasonal change reduced transmission; increased social distancing or school closures reduced contacts; natural depletion of susceptibles, oeB1
- (b) Answer: Seasonal factors or increased social distancing could have reduced transmission, so the fall may not be solely due to vaccination.
Question 34
- (a) vaccine introduces harmless form of antigen so lymphocytes produce specific antibodiesM1
- (a) memory cells are produced which provide long term immunity caoA1
- (a) Answer: A vaccine introduces harmless antigen so lymphocytes produce specific antibodies and form memory cells that give long term immunity.
- (b) one correct reason and effect, e.g. people with weakened immune systems cannot be vaccinated, but herd immunity reduces spread protecting them, oeB1
- (b) Answer: Some people with weak immune systems cannot be vaccinated, but herd immunity reduces disease spread and helps protect them.
Question 35
- a mouse (or other animal) is injected with the chosen antigen, stimulating an immune responseB1
- lymphocytes in the mouse produce the antibody that is specific/complementary to that antigenB1
- the lymphocytes are fused/combined with a tumour (myeloma) cell to produce a hybridoma cellB1
- the hybridoma cell can both divide/multiply (from the tumour cell) and produce the specific antibody (from the lymphocyte)B1
- hybridoma cells are cloned to produce many identical cells, all producing the same (monoclonal) antibody, which is then collected and purifiedB1
- Answer: Indicative content - award any 5 of the marking points listed, max 5 marks.
Question 36
- (a) antibiotic kills susceptible bacteria leaving resistant ones to survive and reproduceM1
- (a) Answer: Antibiotics kill susceptible bacteria so resistant bacteria survive and reproduce, increasing their proportion.
- (b) resistance genes can be transferred via plasmids by conjugation or by other horizontal gene transfer mechanisms, oeM1
- (b) Answer: Resistance genes can spread via plasmids transferred between bacteria by conjugation or other horizontal gene transfer.
- (c) one correct human action and explanation, e.g. overuse or incomplete courses of antibiotics increases selection pressure allowing resistant strains to dominate, oeM1
- (c) Answer: Overuse of antibiotics or patients not completing courses increases selection pressure so resistant strains are more likely to survive and spread.
Question 37
- (a) preclinical testing is carried out on cells, tissues and/or live animals in the laboratory, oeM1
- (a) purpose: to test the drug for toxicity, dosage and efficacy before it is tested on human volunteers, protecting patient safety, oeA1
- (a) Answer: Preclinical testing uses cells, tissues and live animals in the laboratory. Purpose: to check the drug's toxicity, dosage and efficacy before human testing, protecting the safety of human volunteers.
- (b) clinical trials test the drug on healthy volunteers then patients to find the optimum dose and check for side effects; in a double-blind trial neither the patient nor the doctor knows who has the drug or the placebo, which reduces bias in the results, oeB1
- (b) Answer: Clinical trials test the drug first on healthy volunteers, then patients, to find the optimum dose and check for side effects. In a double-blind trial neither the patient nor the doctor knows who has received the drug or the placebo, which reduces bias in the results.
Question 38
- (a) shows substitution: 1 - 1/3.5M1
- (b) 71.4% caoA1
- (b) Answer: 71.4%
- (c) 17857 or 17858 depending on rounding policy (correct computed value 0.7142857 x 25000 = 17857.1425 so 17858 rounded up acceptable), or 17850 if the candidate uses the rounded 71.4% from part (b) (0.714 x 25000), caoA1
- (c) Answer: 17858 people
Question 39
- (a) the test contains monoclonal antibodies (bound to a coloured dye) that are specific/complementary to the hormone hCG, found in the urine of pregnant womenB1
- (a) if hCG is present, it binds to the antibody-dye complex, forming an antibody-antigen complex that moves along the test stripB1
- (a) this complex binds to a second set of fixed antibodies at the test window, concentrating the dye and producing a visible line/colour changeB1
- (a) Answer: Dye-linked monoclonal antibodies bind specifically to hCG in urine; this complex binds to a second fixed antibody in the test window, concentrating the dye to show a positive result.
- (b) monoclonal antibodies are produced that bind specifically to antigens found only on the surface of cancer cells (and not healthy cells)B1
- (b) a toxic drug or radioactive substance can be attached to the antibody, and is delivered directly/only to the cancer cellsB1
- (b) healthy cells are not targeted/damaged, so there are fewer side effects than with chemotherapy, which affects healthy cells tooB1
- (b) Answer: Because the antibodies bind only to cancer-cell antigens, an attached drug/radioactive substance is delivered specifically to cancer cells, sparing healthy cells and reducing side effects compared with chemotherapy.
Question 40
- Level 3 Detailed evaluation: clear balanced judgement supported by multiple reasons and evidence relating to effectiveness, logistics, side effects and public health impact.5-6
- Level 2 Some balanced points with limited justification. Addresses at least two relevant factors with some development.3-4
- Level 1 Limited statements or simple points about one or two factors, little or no development.1-2
- Indicative content:
- Combined vaccines reduce number of injections so increase uptake and compliance, improving herd immunity and public health coverage.
- Fewer clinic visits reduce logistics costs and demand on healthcare staff, and simplify immunisation schedules.
- Combined vaccines may reduce the risk of missing one component, but mixing antigens might slightly reduce immune response to one component in some cases; manufacturers design combinations to avoid interference.
- Risk of side effects: combined vaccine may have cumulative adverse reactions; however clinical trials usually show acceptable safety profiles. Single vaccines allow identification of which component caused a reaction.
- Cold chain and manufacturing complexity: combined vaccines can be more complex to produce and may require careful storage; single vaccines can be distributed independently if supply issues occur.
- Final judgement should weigh likely gains in vaccination coverage and public health benefit against slightly increased complexity in production and potential for compounded side effects; for most programmes combined vaccines are advantageous but context and evidence should guide decision.
Question 41
- Level 1 Statements are made with limited reasoning; little or no reference to both vaccination and monoclonal antibodies.1-2
- Level 2 Some relevant points are made about both vaccination and monoclonal antibodies, with some reasoning or justification; a partial conclusion may be given.3-4
- Level 3 A well-reasoned, balanced evaluation is given, covering both vaccination and monoclonal antibodies, with a justified conclusion supported throughout by scientific reasoning.5-6
- Indicative content:
- Vaccination stimulates the body's own immune system to produce antibodies and memory cells, giving long-term protection
- Vaccination can be given to a large proportion of the population, reducing spread through herd immunity, so is more suitable for preventing a wider outbreak/pandemic
- Vaccination takes time (weeks) to produce full immunity and does not directly help someone who is already seriously ill
- Monoclonal antibodies can be produced to target the virus's antigens specifically and could be given as an immediate treatment to patients who are already infected
- Monoclonal antibody treatment does not rely on the patient's own immune response, so it may act faster or be more suitable for patients with a weakened immune system
- Monoclonal antibody treatment does not give long-term immunity and would need to be manufactured and administered repeatedly, which may be more costly and harder to produce at scale than a vaccine
- A balanced conclusion might use vaccination to prevent spread in the wider population, alongside monoclonal antibodies to treat those already infected
Mark your answers
Check answers without an account. Some answers can be checked automatically; use the mark scheme to mark the rest.